<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03343470</url>
  </required_header>
  <id_info>
    <org_study_id>Adrenal_2</org_study_id>
    <nct_id>NCT03343470</nct_id>
  </id_info>
  <brief_title>The Circadian Rhythm in CusHing SyndrOme in Active Phase and dUring RemiSsion (TheHOURS)</brief_title>
  <acronym>TheHOURS</acronym>
  <official_title>The Observational Prospective Multicentric Study on Melatonin and Cortisol Circadian Rhythm in CusHing SyndrOme Patients in Active Phase and dUring RemiSsion.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Palermo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Florence</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedali Riuniti Ancona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational, open, prospective multi-centre study designed to evaluate melatonin
      and cortisol circadian rhythm, immunological profile and anthropometric parameters in Cushing
      Syndrome patients during active Remission state.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cushing Syndrome is a severe condition caused by prolonged exposure to high levels of
      glucocorticoids.

      This is a disease with high morbidity and mortality due to metabolic, cardiovascular,
      coagulative, psychiatric complications of hypercortisolism.

      The loss of circadian secretion of cortisol is one of the most sensitive and specific
      diagnostic features of Cushing's Syndrome that normalizes during remission. The evaluation of
      the circadian rhythm of cortisol is one of the diagnostic tests recommended by the guidelines
      to evaluate the state of the disease's activity.

      Studies in literature have shown several correlations between states of hypercortisolism and
      circadian secretion of melatonin, displaying reduced melatonin secretion throughout the day
      and the suppression of circadian rhythm of cortisol. However, the dynamics of the
      normalization of melatonin circadian rhythm during remission from Cushing syndrome are
      unclear.

      Therefore, the aim of our study is to evaluate the changes in circadian secretion of
      melatonin in Cushing's syndrome during active disease and during remission (3 and 6 months),
      according to the rational scientific influence of endogenous hypercortisolism on the function
      of the pineal gland. In addition, the changes in circadian secretion of cortisol, of
      mononuclear cells of the blood (PBMC) and of anthropometric-metabolic parameters, will be
      analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2018</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change from baseline in measurement of melatonin secretion at 3 and 6 months</measure>
    <time_frame>0, +3 months, +6 months</time_frame>
    <description>single outcome measurement of melatonin secretion</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of immunological profile at baseline, 3 and 6 months</measure>
    <time_frame>0, +3 months, +6 months</time_frame>
    <description>composite outcome measure consisting of simultaneous measurement of: PBMC profiling with flow cytometry, Full count blood cell</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of cortisol circadian rhythm</measure>
    <time_frame>0, +3 months, +6 months</time_frame>
    <description>single outcome measure of circadian cortisol secretion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in measurement of anthropometric-metabolic parameters at 3 and 6 months</measure>
    <time_frame>0, +3 months, +6 months</time_frame>
    <description>composite outcome measure consisting of simultaneous measurement of:body weight (kg), waist circumference (cm), blood pressure and pulse</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Cushing Syndrome</condition>
  <arm_group>
    <arm_group_label>Cushing Syndrome (active phase)</arm_group_label>
    <description>Patients displaying biochemical and clinical features of active Cushing's syndrome</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cushing Syndrome (during remission)</arm_group_label>
    <description>Patients at 3-6 months from remission with cortisol levels in the normal range</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cushing Syndrome patients in active phase and during remission at 3 and 6 months.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cushing Syndrome during active phase

        Exclusion Criteria:

          -  Malignancy

          -  Alcoholism or drug addiction

          -  Psychiatric disorders

          -  Clinical or laboratory signs of significant cardiovascular, hepatobiliary disease

          -  Clinically significant renal dysfunction

          -  Pregnancy

          -  Any medication with agents which could interfere with glucocorticoid kinetics and
             melatonin secretion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea M Isidori, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Experimental Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea M Isidori, MD, PhD</last_name>
    <phone>+390649970540</phone>
    <email>andrea.isidori@uniroma1.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Experimental Medicine</name>
      <address>
        <city>Rome</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea M Isidori, MD, PhD</last_name>
      <phone>+390649970540</phone>
      <email>andrea.isidori@uniroma1.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Tomova A, Kumanov P, Robeva R, Manchev S, Konakchieva R. Melatonin secretion and non-specific immune responses are differentially expressed in corticotropin-dependent and corticotropin-independent Cushing's syndrome. Med Sci Monit. 2008 Jun;14(6):CR327-332.</citation>
    <PMID>18509277</PMID>
  </results_reference>
  <results_reference>
    <citation>Pivonello R, De Leo M, Cozzolino A, Colao A. The Treatment of Cushing's Disease. Endocr Rev. 2015 Aug;36(4):385-486. doi: 10.1210/er.2013-1048. Epub 2015 Jun 11. Review.</citation>
    <PMID>26067718</PMID>
  </results_reference>
  <results_reference>
    <citation>Piovesan A, Terzolo M, Borretta G, Torta M, Buniva T, Osella G, Paccotti P, Angeli A. Circadian profile of serum melatonin in Cushing's disease and acromegaly. Chronobiol Int. 1990;7(3):259-61.</citation>
    <PMID>2268888</PMID>
  </results_reference>
  <results_reference>
    <citation>Fevre-Montange M, Tourniaire J, Estour B, Bajard L. 24 hour melatonin secretory pattern in Cushing's syndrome. Clin Endocrinol (Oxf). 1983 Aug;19(2):175-81.</citation>
    <PMID>6684004</PMID>
  </results_reference>
  <results_reference>
    <citation>Angeli A, Gatti G, Sartori ML, Masera RG. Chronobiological aspects of the neuroendocrine-immune network. Regulation of human natural killer (NK) cell activity as a model. Chronobiologia. 1992 Jul-Dec;19(3-4):93-110. Review.</citation>
    <PMID>1478121</PMID>
  </results_reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2017</study_first_submitted>
  <study_first_submitted_qc>November 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>January 25, 2018</last_update_submitted>
  <last_update_submitted_qc>January 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Andrea M. Isidori</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Cushing Syndrome</keyword>
  <keyword>Adrenal Insufficiency</keyword>
  <keyword>Peripheral blood mononuclear cells</keyword>
  <keyword>Melatonin</keyword>
  <keyword>Cortisol</keyword>
  <keyword>Immunological profile</keyword>
  <keyword>Cushing Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Cushing Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

